Get the Stockscreener App
0.078
3.17%
0.0024
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Prophase Labs Inc stock is traded at $0.078, with a volume of 271.95K.
It is up +3.17% in the last 24 hours and down -8.98% over the past month.
PROPHASE LABS INC
See More
Previous Close:
$0.0756
Open:
$0.0781
24h Volume:
271.95K
Relative Volume:
6.52
Market Cap:
$N/A
Revenue:
$7.33M
Net Income/Loss:
$-21.20M
P/E Ratio:
-0.0853
EPS:
-0.9143
Net Cash Flow:
$-12.68M
1W Performance:
+3.17%
1M Performance:
-8.98%
6M Performance:
-95.33%
1Y Performance:
-96.64%
1-Day Range:
$0.0712
$0.0806
1-Week Range:
$0.0712
$0.0806
52-Week Range:
$0.07
$0.1199
Prophase Labs Inc Stock (PRPH) Company Profile
Name
Prophase Labs Inc
Sector
Industry
Phone
-
Address
-
Compare PRPH vs TMO, DHR, IDXX, NTRA, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PRPH
Prophase Labs Inc
|
0.078 | 0 | 7.33M | -21.20M | -12.68M | -0.9143 |
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Prophase Labs Inc Stock (PRPH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-20-21 | Initiated | H.C. Wainwright | Buy |
| Oct-13-21 | Downgrade | Dawson James | Buy → Neutral |
| Jan-20-21 | Initiated | Dawson James | Buy |
Prophase Labs Inc Stock (PRPH) Latest News
ProPhase Labs, Inc. (PRPH) Q1 2026 10-Q: Financials, Stock Info, and Key SEC Filing Details - Minichart
ProPhase Labs, Inc. 1Q 2026: Revenue $478K, EPS $(0.43) — 10-Q Summary - TradingView
ProPhase Labs (PRPH) flags going concern risk after Q1 2026 loss and heavy financing - Stock Titan
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Price to sales forward of ProPhase Labs, Inc. – OTC:PRPH - TradingView
ProPhase Labs, Inc. Actuals & Estimates (OTC:PRPH) - TradingView
Prophase Labs Inc (PRPH) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
ProPhase Labs StockLong-term business model and market position - AD HOC NEWS
Prophase Labs Inc (PRPH) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Prophase Labs Inc (PRPH) Valuation: PE, PB & Fair Value Analysis - TradingKey
Prophase Labs Inc (PRPH) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Prophase Labs Inc (PRPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Prophase Labs Inc (PRPH) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
ProPhase Labs, Inc. 2025 Annual Report: Genomics, Biotech, Diagnostics, and Supplement Innovations Overview - Minichart
ProPhase Labs, Inc. FY 2025: Revenue $4.35M, EPS ($1.74) — 10-K Summary - TradingView
[10-K] ProPhase Labs, Inc. Files Annual Report - Stock Titan
ProPhase Labs, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
MSN Money - MSN
PRPH | PROPHASE LABS INC Insider Trading - Quiver Quantitative
ProPhase Labs stock (US74345W1080): earnings update and shifting focus beyond COVID testing - AD HOC NEWS
ProPhase Labs Delays Quarterly Financial Filing - TipRanks
ProPhase Labs (NASDAQ: PRPH) delays Q1 2026 10-Q amid 2025 audit - Stock Titan
ProPhase Labs stock (US74345W1080): Reverse stock split raises questions - AD HOC NEWS
TradingKey - TradingKey
Prophase Labs Stock Price Forecast. Should You Buy PRPH? - StockInvest.us
ProPhase Testing Units Creditor Says No Real Ch. 11 Progress - Law360
PROPHASE LABS INC by ProPhase Labs, Inc. Analyst Ratings and Price Targets | OTC:PRPH - Benzinga
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
ProPhase Labs earnings missed by $2.47, revenue fell short of estimates - Investing.com Canada
ProPhase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform - The Manila Times
ProPhase Labs Reports Year-End 2025 Results, Highlights - GlobeNewswire
Geopolitics Watch: What analysts say about ProPhase Labs Inc stock2026 Gainers & Target Return Focused Stock Picks - baoquankhu1.vn
ETF Watch: Is ProPhase Labs Inc exposed to political riskMarket Movement Recap & Weekly Stock Breakout Alerts - baoquankhu1.vn
Street Watch: Is ProPhase Labs Inc exposed to currency risksRate Cut & Daily Profit Focused Stock Screening - baoquankhu1.vn
Earnings Update: How much upside does ProPhase Labs Inc have2026 Recap & Stepwise Swing Trade Plans - baoquankhu1.vn
Will ProPhase Labs Inc outperform the market in YEARTrade Performance Summary & Safe Entry Point Alerts - baoquankhu1.vn
Nasdaq Moves: Will ProPhase Labs Inc benefit from AI trends2026 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Market Review: Whats next for ProPhase Labs Inc stock2026 Big Picture & Growth Oriented Trading Recommendations - baoquankhu1.vn
ProPhase Labs (NASDAQ:PRPH) versus Medicure (OTCMKTS:MCUJF) Financial Contrast - Defense World
ProPhase Labs, Inc. (PRPH) stock price, news, quote and history - Yahoo Finance UK
Risk Hedge: Is ProPhase Labs Inc exposed to political risk2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
Quarterly Risk: How does ProPhase Labs Inc score in quality rankings2026 Trading Recap & Accurate Buy Signal Alerts - baoquankhu1.vn
ProPhase Labs Delays Annual 10-K Yearly Filing - TipRanks
ProPhase Labs (PRPH) notifies SEC of delayed FY2025 10-K; expects 15-day filing - Stock Titan
Guidance Update: Is ProPhase Labs Inc exposed to political risk2026 Snapshot & Weekly High Return Opportunities - baoquankhu1.vn
Trend Recap: What analysts say about ProPhase Labs Inc stockIndex Update & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Investment Recap: How much upside does ProPhase Labs Inc have2026 Macro Impact & Verified Entry Point Detection - baoquankhu1.vn
Gains Report: What analysts say about ProPhase Labs Inc stockQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
ProPhase Labs (PRPH) Updates on Crown Medical Collections Progre - GuruFocus
ProPhase Labs provides business update highlighting advancing Crown Medical collections activity - marketscreener.com
ProPhase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity - The Manila Times
Prophase Labs Inc Stock (PRPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.14%
0.62%
Cap:
|
Volume (24h):